AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 18-A-06-031.02
We recommend that the State agency strengthen internal controls to ensure the invoice recalculation step is performed when needed so that all…
The recommendation, in the publisher's words
We recommend that the State agency strengthen internal controls to ensure the invoice recalculation step is performed when needed so that all managed-care pharmacy drugs eligible for rebate are invoiced.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- December 12, 2017
- Report
- Texas Did Not Bill Manufacturers for Some Rebates for Pharmacy Drugs of Medicaid Managed-Care Organizations (A-06-16-00004) · find it at HHS OIG
- Kind of report
- Audit
- Agency response
- Concur (as recorded by the publisher)
- Closed
- May 21, 2018 (publisher's date)
- Publisher topics
- Managed Care, Prescription Drug
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
1 more, of which 0 are open in the publisher's file.
- We recommend that the State agency invoice manufacturers for the $7,768,891 ($4,438,368 Federal share) in rebates, and refund the Federal share of rebates collected; andHHS OIG 18-A-06-031.01 · issued Dec 12, 2017 · closed May 21, 2018Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.